PDA Letter Article

Adapt Your Nest-and-Tub System as the Industry Evolves

by Gregor Deutschle, SCHOTT


For roughly the past half-decade, the pharmaceutical industry has been responding to a drought in blockbuster cures with high-value biologics, treatments for rare diseases and targeted medicines. As life-changing as these can be for patients—and as rewarding as they can be for pharmaceutical companies—they also present challenges to the manufacturing infrastructure. Yet the secret to successful flexible manufacturing may lie in a mainstay of the industry—standardized secondary packaging components.